Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: A randomized, double-blind trial

American Journal of Medicine

Volumn 116, Issue 4, 2004, Pages 223-229

  Dailey III, George E ^a   Noor, Mustafa A ^b   Park, Jong Soon ^b   Bruce, Simon ^b   Fiedorek, Fred T ^b  

^a SCRIPPS CLINIC   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE PLUS METFORMIN; GLUCOSE; HEMOGLOBIN A1C; PLACEBO; ROSIGLITAZONE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BONE PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDEMA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT GAIN;

EID: 1242328748     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.07.022     Document Type: Article

References (14)

1. DeFronzo R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 131:1999;281-303.
2. Turner R.C., Cull C.A., Frighi V., et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group . JAMA. 281:1999;2005-2012.
3. Hawkins D., Bradberry J.C., Cziraky M.J., et al. National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus toward better patient outcomes and new roles for pharmacists . Pharmacotherapy. 22:2002;436-444.
4. Riddle M. Combining sulfonylureas and other oral agents. Am J Med. 108:(suppl 6A):2000;15S-22S.
5. Bell D.S., Ovalle F. Long-term efficacy of triple oral therapy for type 2 diabetes mellitus. Endocr Pract. 8:2002;271-275.
6. Texas Diabetes Council. Glycemic control algorithm for type 2 diabetes mellitus in adults. Available at: http://www.tdh.state.tx.us/diabetes/tdc.htm . Accessed December 18, 2002.
7. New Jersey Association of Health Plans. New Jersey consensus guidelines for diabetes. Algorithm for diabetes. Available at: http://www.njahp.org/pdf/ final_algorithm.pdf . Accessed December 18, 2002.
8. Avandia (rosiglitazone maleate) tablets. 2001;GlaxoSmithKline, Research Triangle Park, North Carolina. [prescribing information].
9. Gavin L.A., Barth J., Arnold D., et al. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control. Endocr Pract. 6:2000;305-310.
10. Yale J.F., Valiquett T.R., Ghazzi M.N., et al. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial. Ann Intern Med. 134:2001;737-745.
11. May L.D., Lefkowitch J.H., Kram M.T., et al. Mixed hepatocellular- cholestatic liver injury after pioglitazone therapy. Ann Intern Med. 136:2002;449-452.
12. Forman L.M., Simmons D.A., Diamond R.H. Hepatic failure in a patient taking rosiglitazone. Ann Intern Med. 132:2000;118-121.
13. Al Salman J., Arjomand H., Kemp D.G., et al. Hepatocellular injury in a patient receiving rosiglitazone. A case report. Ann Intern Med. 132:2000;121-124.
14. Peters A.L. Using thiazolidinediones rosiglitazone and pioglitazone in clinical practice . Am J Manag Care. 7:(suppl 3):2001;S87-S95.